Sections

Akili raises $30.5m for medical treatment games

Games used to treat autism spectrum disorder, ADHD and depression

Akili, a company that creates software-based medical treatments and monitors that function as video games, has just announced $30.5 million in new equity investments.

"The need for safe and effective treatment of cognitive disorders, including ADHD and autism, continues to grow, and new modalities are needed for millions of patients. Particularly in pediatric populations, we see a significant demand for non-pharmacological options," said CEO Eddie Martucci.

"We're excited that, with the support of our new and existing investors, we can continue to advance our adaptive software platform towards clinical validation and commercialization as a fundamentally new type of mainstream medicine."

Investors included JAZZ Venture Partners, Canepa Advanced Healthcare Fund and PureTech Health.

"We're seeing the emergence of an entirely new category of non-pharmacological therapies, and Akili is leading the charge. We love their ability to target some of the most under-served patient populations and disrupt massive markets at the same time," added John Spinale, former SVP of Social Games at Disney, and Partner at JAZZ Venture Partners.

Related stories

Starbreeze up-lists to Nasdaq Stockholm

Leaving First North Premier exchange will increase its reach with potential investors

By Matthew Handrahan

HTC Vive giving devs 100% of Viveport revenue for holidays

Company also increasing rev share on Viveport Arcade Manager and leading $4m investment into VRChat

By James Brightman

Latest comments

Sign in to contribute

Need an account? Register now.